SCHEMBL206148

SCHEMBL206148

FC(F)(F)c1cc(Nc2nc(-c3ccc(Cl)c(Cl)c3)cs2)ccc1Cl

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 9/20 0.66
VCP P55072 4/20 0.66
CFTR P13569 2/20 0.58
ABL1 P00519 5/20 0.51
MAPT P10636 2/20 0.48
KDM4E B2RXH2 1/20 0.48
POLB P06746 1/20 0.48
GAA P10253 1/20 0.48
RECQL P46063 1/20 0.48
BLM P54132 1/20 0.48
DHODH Q02127 1/20 0.47
MEN1 O00255 1/20 0.47
DEGS1 O15121 1/20 0.47
MAP4K4 O95819 1/20 0.47
CYP3A4 P08684 1/20 0.47
AMY1A P0DUB6 1/20 0.47
ALOX15 P16050 1/20 0.47
TSHR P16473 1/20 0.47
MAPK1 P28482 1/20 0.47
MAPKAPK2 P49137 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL207226 0.90 ALOX5 (0.70) ALOX5VCPMAPTKDM4EMEN1
SCHEMBL206675 0.89 ALOX5 (0.58) ALOX5VCPCFTRMAPTKDM4E
SCHEMBL205976 0.87 ALOX5 (0.80) ALOX5VCPCFTRABL1MAPT
SCHEMBL12297192 0.87 ALOX5 (0.65) ALOX5VCPMAPTGAAMEN1
SCHEMBL12297925 0.85 ALOX5 (0.54) ALOX5VCPCFTRMAPTGAA
SCHEMBL7112167 0.84 ALOX5 (0.75) ALOX5VCPCFTRMAPTKDM4E
SCHEMBL23539585 0.83 VCP (0.79) ALOX5VCPCFTRABL1MAPT
SCHEMBL207250 0.83 MEN1 (0.68) VCPMAPTGAAMEN1MAPK1
SCHEMBL12297437 0.82 PTGS2 (0.61) ALOX5VCPCFTRMAPTGAA
SCHEMBL206333 0.81 ALOX5 (0.77) ALOX5VCPCFTRABL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120108576-A1 THIAZOLE COMPOUNDS AND METHODS OF USE ACHILLION PHARMACEUTICALS, INC. (US) 2012-05-03 US disclosed
US-20120108576-A1 THIAZOLE COMPOUNDS AND METHODS OF USE ACHILLION PHARMACEUTICALS, INC. (US) 2012-05-03 US disclosed
US-20120108576-A1 THIAZOLE COMPOUNDS AND METHODS OF USE ACHILLION PHARMACEUTICALS, INC. (US) 2012-05-03 US disclosed
US-8088806-B2 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. (US) 2012-01-03 US disclosed
US-8088806-B2 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. (US) 2012-01-03 US disclosed
US-8088806-B2 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. (US) 2012-01-03 US disclosed
US-20070004711-A1 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. 2007-01-04 US disclosed
US-20070004711-A1 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. 2007-01-04 US disclosed
US-20070004711-A1 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. 2007-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108576-A1 THIAZOLE COMPOUNDS AND METHODS OF USE PIGS, CPT1A, SLC10A1 ALOX5 3410/4885VCP 1270/4885CFTR 111/4885
US-20070004711-A1 Thiazole compounds and methods of use PIGS, CPT1A, SLC10A1 ALOX5 3410/4885VCP 1270/4885CFTR 111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.